Market Closed -
Abu Dhabi Securities Exchange
06:55:00 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
3.59
AED
|
+2.57%
|
|
+5.28%
|
-37.02%
|
Fiscal Period: December |
2023
|
---|
Capitalization
1 |
63,333
|
Enterprise Value (EV)
1 |
54,378
|
P/E ratio
|
59.3
x
|
Yield
|
-
|
Capitalization / Revenue
|
3.86
x
|
EV / Revenue
|
3.32
x
|
EV / EBITDA
|
-109
x
|
EV / FCF
|
-121,316,235
x
|
FCF Yield
|
-0%
|
Price to Book
|
3.95
x
|
Nbr of stocks (in thousands)
|
11,111,111
|
Reference price
2 |
5.700
|
Announcement Date
|
2/12/24
|
Fiscal Period: December |
2022
|
2023
|
---|
Net sales
1 |
12,486
|
16,399
|
EBITDA
1 |
2,788
|
-497.7
|
EBIT
1 |
2,503
|
-1,217
|
Operating Margin
|
20.05%
|
-7.42%
|
Earnings before Tax (EBT)
1 |
4,286
|
1,384
|
Net income
1 |
3,718
|
964.7
|
Net margin
|
29.78%
|
5.88%
|
EPS
2 |
0.3782
|
0.0961
|
Free Cash Flow
|
-
|
-448.2
|
FCF margin
|
-
|
-2.73%
|
FCF Conversion (EBITDA)
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
2/12/24
|
2/12/24
|
Fiscal Period: December |
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
Net Cash position
1 |
5,460
|
8,955
|
Leverage (Debt/EBITDA)
|
-
|
-
|
Free Cash Flow
|
-
|
-448
|
ROE (net income / shareholders' equity)
|
-
|
7.05%
|
ROA (Net income/ Total Assets)
|
-
|
-2.91%
|
Assets
1 |
-
|
-33,157
|
Book Value Per Share
2 |
1.130
|
1.440
|
Cash Flow per Share
2 |
0.7000
|
0.9500
|
Capex
1 |
231
|
390
|
Capex / Sales
|
1.85%
|
2.38%
|
Announcement Date
|
2/12/24
|
2/12/24
|
|
1st Jan change
|
Capi.
|
---|
| -37.02% | 10.86B | | +25.52% | 88.99B | | -24.52% | 74.82B | | -5.56% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +70.11% | 13.09B | | +79.20% | 13.21B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|